Related Experiment Videos
Low-rate repetitive TMS allays central pain
S Canavero1, V Bonicalzi, M Dotta
1Pain Relief Unit, Department of Neurosciences, Molinette Hospital, Turin, Italy. solara@infinito.it
Neurological Research
|March 15, 2003
Summary
Identifying prognostic factors for central pain treatment is crucial as only half of patients benefit long-term from motor cortex stimulation. Propofol tests and transcranial magnetic stimulation (TMS) show promise in predicting short-term treatment effects, potentially reducing treatment failures.
Area of Science:
- Neurology
- Pain Medicine
- Neurosurgery
Background:
- Motor cortex stimulation (MCS) is a treatment for central pain, but long-term efficacy is limited, with only about 50% of patients responding.
- Predictive factors for treatment success in central pain patients undergoing MCS are currently lacking.
- Identifying prognostic markers is essential to optimize patient selection and improve outcomes.
Purpose of the Study:
- To investigate the predictive value of propofol infusion test and transcranial magnetic stimulation (TMS) for short-term treatment response in central pain patients.
- To identify potential prognostic factors that could help reduce the number of patients who do not benefit from MCS.
Main Methods:
- A study was conducted involving nine patients diagnosed with central pain.
- Propofol infusion test and TMS were administered to assess their predictive capabilities.
- Short-term treatment effects following MCS were evaluated in relation to the test results.
Main Results:
- Both the propofol test and TMS demonstrated the ability to predict short-term treatment response in the studied cohort.
- These findings suggest that these tests may serve as valuable tools for anticipating treatment outcomes.
Conclusions:
- Propofol test and TMS show potential as prognostic factors for short-term efficacy of motor cortex stimulation in central pain.
- Utilizing these predictive measures could aid clinicians in selecting appropriate candidates for MCS, thereby minimizing treatment failures and improving patient management.